Mirum Pharmaceuticals (MIRM) net assets (shareholders' equity)

Net assets · fiscal 2025
$314.69M

Mirum Pharmaceuticals (MIRM) had net assets of $314.69M at the end of fiscal 2025 (December 31, 2025). That is 39.5% higher than the $225.64M of fiscal 2024. Figures as of 19 Nov 2026, 00:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$314.69M
Change on fiscal 2024
+39.5%
Growth, 5 years
+12.8% a year
Highest on record
$314.69Mfiscal 2025
Lowest on record
$120.21Mfiscal 2021
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Mirum Pharmaceuticals net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 12.8% a year. Across the 7 fiscal years on record (2019–2025), the highest was $314.69M in fiscal 2025 and the lowest $120.21M in fiscal 2021.

History · 7 fiscal years

Net assets by fiscal year

Mirum Pharmaceuticals net assets (shareholders' equity), year by year

Mirum Pharmaceuticals (MIRM) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$314.69M 39.5% up
2024$225.64M 9.3% down
2023$248.67M 75.1% up
2022$142.04M 18.2% up
2021$120.21M 30.1% down
2020$172.10M 32.0% up
2019$130.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Mirum Pharmaceuticals and comparable companies
CompanyNet assetsFiscal year
Scholar Rock Holding SRRK$245.49M2025
Teleflex TFX$3.12B2025
Mirum Pharmaceuticals MIRM$314.69M2025
Veradermics MANE$143.46M2025
Grifols GRFS€5.27B2025
Cogent Biosciences COGT$636.37M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MIRM

Mirum Pharmaceuticals, figure by figure

Mirum Pharmaceuticals (MIRM) overview: price, valuation and scorecardAll health care companies by market value

Mirum Pharmaceuticals net assets (shareholders' equity): questions and answers

What are Mirum Pharmaceuticals's net assets?

Mirum Pharmaceuticals (MIRM) had net assets of $314.69M at the end of fiscal 2025 (December 31, 2025). That is 39.5% higher than the $225.64M of fiscal 2024.

What is the growth rate of Mirum Pharmaceuticals's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 12.8% a year.

What are the highest and lowest net assets figures on record for Mirum Pharmaceuticals?

Across the 7 fiscal years on record (2019–2025), the highest was $314.69M in fiscal 2025 and the lowest $120.21M in fiscal 2021.

How is Mirum Pharmaceuticals's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Mirum Pharmaceuticals it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Mirum Pharmaceuticals (MIRM) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/MIRM/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.